RecruitingNCT06820515

ATHNdataset Registry

American Thrombosis and Hemostasis Network ATHNdataset Registry


Sponsor

American Thrombosis and Hemostasis Network

Enrollment

200,000 participants

Start Date

Oct 25, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems. Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with bleeding disorder, blood disorder, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

American Thrombosis and Hemostasis Network

Hickory, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06820515


Related Trials